Weight management barriers and facilitators after breast cancer in Australian women: a national survey
»
Weight management barriers and facilitators after breast cancer in Australian women: a national survey
Background: Breast cancer is the most common cancer in women worldwide. weight gain after breast cancer is associated with poor health outcomes. The purpose of this study was to describe how the Australian breast cancer survivors now manage their weight.
Methods: The online survey of cross-sectional open to any woman living in Australia who identify themselves as having breast cancer, between November 2017 and January 2018. Results: We received 309 responses. Most respondents described their diet as good / excellent and the reported high levels of moderate-weight self-efficacy. Nonetheless, the proportion of overweight / obese increased from 47% at diagnosis to 67% at the time of the survey.
More than three-quarters of respondents did not receive advice on the prevention of weight gain at the time of diagnosis. 39% of women reported being less active after a diagnosis of cancer, and some weight loss interventions that are considered effective. Facilitator structured exercise program, proper diet, and accountability to others, while the often-cited barrier is lack of motivation / willingness, fatigue, and difficulty maintaining body weight. Women who cited fatigue as a barrier nearly two times more likely to commit low levels of physical activity (PA) or no PA than women who did not cite fatigue as a barrier.
Conclusion: We report a high level of concern about weight gain after SM and significant gaps in the provision of services around the prevention of weight gain and weight management. Women with BC should be provided with support for the prevention of weight gain in the initial survival phase, which should include a structured PA and dietary changes in combination with behavior change and social support. Weight loss or prevention of weight loss program must overcome obstacles such as fatigue. Further research is needed on the effectiveness of diet and exercise intervention on Survivor SM, especially with regard to the prevention of weight gain.
Weight management barriers and facilitators after breast cancer in Australian women: a national survey
Genomic Characterization of germline large complex rearrangements of BRCA1 and BRCA2 genes High Risk Breast Cancer Patients-Novel Variant of the National Center for Large
large genomic rearrangements (LGRs) that affects one or more exons of BRCA1 and BRCA2 are an important part of the spectrum of mutations in this gene. Since 2004, the National Institute of Oncology, Hungary, has been involved in screening for LGRs breast or ovarian cancer families registered for genetic testing. LGRs detected by the probe multiplex ligation amplification method, or next-generation sequencing. Where it is possible, transcript-level characterization LGRs do.
Phenotype data collected and analyzed as well. Altogether 28 species LGRs in 51 probands were detected. Sixteen LGRs new. Forty-nine cases are deletions or duplications in the BRCA1 and BRCA2 are two affected. Rearrangements accounted for 10% of BRCA1. Three exons copy of profit, two complex rearrangements, and 23 losses exons are marked by the determination of the appropriate breakpoint.
Description: Enzyme-linked immunosorbent assay kit for quantification of Rat Peripheral myelin protein 22 in samples from serum, plasma, tissue homogenates and other biological fluids.
Description: A sandwich quantitative ELISA assay kit for detection of Rat Peripheral Myelin Protein 22 (PMP22) in samples from tissue homogenates, cell lysates or other biological fluids.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: A sandwich quantitative ELISA assay kit for detection of Rat Peripheral Myelin Protein 22 (PMP22) in samples from tissue homogenates, cell lysates or other biological fluids.
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Peripheral Myelin Protein 22 (PMP22) in tissue homogenates, cell lysates and other biological fluids.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Peripheral Myelin Protein 22 (PMP22) in tissue homogenates, cell lysates and other biological fluids.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Peripheral Myelin Protein 22 (PMP22) in tissue homogenates, cell lysates and other biological fluids.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Peripheral Myelin Protein 22 (PMP22) in tissue homogenates, cell lysates and other biological fluids.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Peripheral Myelin Protein 22 (PMP22) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species.
Rat Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: Quantitative sandwich ELISA for measuring Rat Peripheral myelin protein 22 (PMP22) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.
ELISA kit for Rat Peripheral myelin protein 22 (PMP22)
Description: Quantitative sandwich ELISA for measuring Rat Peripheral myelin protein 22 (PMP22) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.
ELISA kit for Rat Peripheral myelin protein 22 (PMP22)
Description: Quantitative sandwich ELISA for measuring Rat Peripheral myelin protein 22 (PMP22) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.
ELISA kit for Rat PMP22 (Peripheral Myelin Protein 22)
Description: A sandwich ELISA kit for detection of Peripheral Myelin Protein 22 from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids.
Human  Peripheral  Blood  CD4+  T  Lymphocytes, Fresh
Description: Cryopreserved vial (30 x 10^6 cells) of freshly isolated primary human peripheral blood mononuclear cells (PBMCs) from a healthy donor, isolated from leukapheresis / apheresis samples using Ficoll gradient. After isolation, the PBMCs were stained to identify sub populations and evaluated for viability by flow cytometry. Cells were cryopreserved in serum-free Cryostor CS10 at a controlled rate.
Description: Human peripheral blood leukocyte tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human peripheral blood leukocyte tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated peripheral blood leukocyte tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated peripheral blood leukocyte tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Peripheral myelin protein 22 in samples from serum, plasma, tissue homogenates and other biological fluids.
Single Donor Human Peripheral Blood Mononuclear Cells (PBMC) Frozen
Description: MECA-79 recognizes a carbohydrate epitope shared with a group of sulfation decorated sialomucins, including sulfated ligands for CD62L (CD34, GlyCAM-1, Sgp200, and a subset of MAdCAM-1). This set antigens has been referred to as peripheral node addressin (PNAd) with the molecular mass 50-250 kD. It has been identified that GlcNAc-6-SO4 sulfation contributes to MECA-79 binding and the core 1 beta1,3-N-acetylglucosaminyltransferase is required for the generation of the MECA-79 epitope. MECA-79 is expressed on high endothelial venules (HEV) of lymphoid tissues, chronic inflamed tissues and rheumatoid synovia. The interaction of PNAd with CD62L receptor is involved in tethering and rolling of lymphocytes along HEV in lymphoid tissues. MECA-79 antibody reacts with Mouse, human and many other species PNAd and blocks L-selectin-dependent lymphocyte adhesion in vitro and in vivo.
Description: MECA-79 recognizes a carbohydrate epitope shared with a group of sulfation decorated sialomucins, including sulfated ligands for CD62L (CD34, GlyCAM-1, Sgp200, and a subset of MAdCAM-1). This set antigens has been referred to as peripheral node addressin (PNAd) with the molecular mass 50-250 kD. It has been identified that GlcNAc-6-SO4 sulfation contributes to MECA-79 binding and the core 1 beta1,3-N-acetylglucosaminyltransferase is required for the generation of the MECA-79 epitope. MECA-79 is expressed on high endothelial venules (HEV) of lymphoid tissues, chronic inflamed tissues and rheumatoid synovia. The interaction of PNAd with CD62L receptor is involved in tethering and rolling of lymphocytes along HEV in lymphoid tissues. MECA-79 antibody reacts with Mouse, human and many other species PNAd and blocks L-selectin-dependent lymphocyte adhesion in vitro and in vivo.
Description: MECA-79 recognizes a carbohydrate epitope shared with a group of sulfation decorated sialomucins, including sulfated ligands for CD62L (CD34, GlyCAM-1, Sgp200, and a subset of MAdCAM-1). This set antigens has been referred to as peripheral node addressin (PNAd) with the molecular mass 50-250 kD. It has been identified that GlcNAc-6-SO4 sulfation contributes to MECA-79 binding and the core 1 beta1,3-N-acetylglucosaminyltransferase is required for the generation of the MECA-79 epitope. MECA-79 is expressed on high endothelial venules (HEV) of lymphoid tissues, chronic inflamed tissues and rheumatoid synovia. The interaction of PNAd with CD62L receptor is involved in tethering and rolling of lymphocytes along HEV in lymphoid tissues. MECA-79 antibody reacts with Mouse, human and many other species PNAd and blocks L-selectin-dependent lymphocyte adhesion in vitro and in vivo.
Human Peripheral Myelin Protein 22 (PMP22) CLIA Kit
Description: A sandwich quantitative ELISA assay kit for detection of Human Peripheral Myelin Protein 22 (PMP22) in samples from tissue homogenates, cell lysates or other biological fluids.
Human Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: A sandwich quantitative ELISA assay kit for detection of Human Peripheral Myelin Protein 22 (PMP22) in samples from tissue homogenates, cell lysates or other biological fluids.
Mouse Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Peripheral Myelin Protein 22 (PMP22) in samples from tissue homogenates, cell lysates or other biological fluids.
Mouse Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Peripheral Myelin Protein 22 (PMP22) in samples from tissue homogenates, cell lysates or other biological fluids.
Human Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Peripheral Myelin Protein 22 (PMP22) in Tissue homogenates, cell lysates and other biological fluids.
Human Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Peripheral Myelin Protein 22 (PMP22) in Tissue homogenates, cell lysates and other biological fluids.
Human Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Peripheral Myelin Protein 22 (PMP22) in Tissue homogenates, cell lysates and other biological fluids.
Human Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Peripheral Myelin Protein 22 (PMP22) in Tissue homogenates, cell lysates and other biological fluids.
Human Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Peripheral Myelin Protein 22 (PMP22) in samples from Tissue homogenates, cell lysates and other biological fluids. with no significant corss-reactivity with analogues from other species.
Mouse Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Peripheral Myelin Protein 22 (PMP22) in Tissue homogenates, cell lysates and other biological fluids.
Mouse Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Peripheral Myelin Protein 22 (PMP22) in Tissue homogenates, cell lysates and other biological fluids.
Mouse Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Peripheral Myelin Protein 22 (PMP22) in Tissue homogenates, cell lysates and other biological fluids.
Mouse Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Peripheral Myelin Protein 22 (PMP22) in Tissue homogenates, cell lysates and other biological fluids.
Mouse Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Peripheral Myelin Protein 22 (PMP22) in samples from Tissue homogenates, cell lysates and other biological fluids. with no significant corss-reactivity with analogues from other species.
Human Peripheral Myelin Protein 22 (PMP22) ELISA Kit
Description: Cryopreserved vial (30 x 10^6 cells) of freshly isolated primary human peripheral blood mononuclear cells (PBMCs) from a healthy donor, isolated from leukapheresis / apheresis samples using Ficoll gradient. After isolation, the PBMCs were stained to identify sub populations and evaluated for viability by flow cytometry. Cells were cryopreserved in serum-free Cryostor CS10 at a controlled rate.
Rat Tight Junction Associated Protein 1, Peripheral (TJAP1) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Tight Junction Associated Protein 1, Peripheral (TJAP1) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
Rat Tight Junction Associated Protein 1, Peripheral (TJAP1) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Tight Junction Associated Protein 1, Peripheral (TJAP1) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
Rat Tight Junction Associated Protein 1, Peripheral (TJAP1) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Tight Junction Associated Protein 1, Peripheral (TJAP1) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
Rat Tight Junction Associated Protein 1, Peripheral (TJAP1) ELISA Kit
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Tight Junction Associated Protein 1, Peripheral (TJAP1) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids.
Rat Tight Junction Associated Protein 1, Peripheral (TJAP1) ELISA Kit
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Tight Junction Associated Protein 1, Peripheral (TJAP1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species.
Peripheral Myelin Protein 22 (PMP22) Blocking Peptide
Description: A sandwich ELISA kit for detection of Peripheral Myelin Protein 22 from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.
ELISA kit for Mouse Peripheral myelin protein 22 (PMP22)
Description: Quantitative sandwich ELISA for measuring Mouse Peripheral myelin protein 22 (PMP22) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.
ELISA kit for Mouse Peripheral myelin protein 22 (PMP22)
Description: Quantitative sandwich ELISA for measuring Mouse Peripheral myelin protein 22 (PMP22) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.
ELISA kit for Mouse Peripheral myelin protein 22 (PMP22)
Description: Quantitative sandwich ELISA for measuring Mouse Peripheral myelin protein 22 (PMP22) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.
ELISA kit for Mouse PMP22 (Peripheral Myelin Protein 22)
Description: A sandwich ELISA kit for detection of Peripheral Myelin Protein 22 from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids.
Recombinant Human Peripheral Myelin Protein-2, His Tag
Description: PMP2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 132 amino acids and having a molecular mass of 14.9 kDa.
Peripheral Myelin Protein 22 (PMP22) Polyclonal Antibody (Human)
Description: A Rabbit polyclonal antibody against Human Peripheral Myelin Protein 22 (PMP22). This antibody is labeled with Cy3.
×
LGR concluded mechanism for the formation of mainly end-joining repair utilizes short homologies directly. Comparing the phenotypic features of LGR carriers to that of non-LGR carriers of BRCA1 mutation, revealed no significant differences. Our study is the largest comprehensive report LGRs of BRCA1 / 2 in familial breast and ovarian cancer patients in the region of Central and Eastern Europe. Our data add new insights to the interpretation genetically related to LGRs.
